+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-09-13Number of Pages: 170

Poultry Pharmaceuticals Market (Product Type - Drugs, Vaccines, Feed Additive, Medication; Animal Type - Chicken, Turkey, Duck, Goose) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Poultry Pharmaceuticals Market: Snapshot

Poultry farms and products are gaining importance among the human population as a profitable business and as a key food source. Technological advancements, rising vaccination programs, and the growing focus on preventive healthcare for livestock are the key factors supporting the global poultry pharmaceuticals market.

Poultry animals are more prone to diseases such as coccidiosis and avian influenza caused by environmental conditions, improper waste management, and improper feed additives. Poultry health has become a major cause for concern among consumers, especially as the demand for meat and protein sources soars globally. This has significantly fueled the demand for poultry pharmaceuticals.

The opportunity presented by the global poultry pharmaceuticals market stood at US$3.7 bn in 2015 and is estimated to reach US$7.8 bn by 2024 at a strong CAGR of 8.5% therein.

Growing Usage of Feed Additive Medication a Positive Sign for Poultry Pharmaceutical Market

Based on product type, the poultry pharmaceuticals market comprises drugs, vaccines, and feed additive medication. Vaccines are primarily used by poultry farmers for the immunization of poultry animals due to their immediate effect. Hence, the vaccines segment led the global poultry pharmaceuticals market in 2015. Poulvac, the most commonly used vaccine in poultry animals, is likely to dominate the vaccine segment from 2016 to 2024. The usage of feed additive medication for poultry animals is increasing rapidly in recent years owing to their easy dissolving ability with feed given to the animals. The market for drugs is expected to expand at a high growth rate during the forecast period.

By type of animal, chicken emerged as the leading segment of the global poultry pharmaceuticals market in 2015. The dominance of this segment can be attributed to the popularity of the animal among meat eaters across the globe. The quality of meat and its health benefits drive the consumption of chicken. Duck meat also held a significant share in the poultry pharmaceutical market due to its lean, tender meat and fatty liver. Duck eggs are more popular among humans due to high protein content. Duck farming is expected to witness strong growth in terms of volume by 2024.

poultry-pharmaceuticals-market

Latin America Presents Lucrative Opportunities for Global Players

North America was the leading market for poultry pharmaceuticals in 2015 owing to the high adoption of as well as awareness regarding animal healthcare products and the growing demand for feed additive medication. In addition, increasing concerns about re-emerging poultry diseases drive the poultry pharmaceuticals market in North America. The U.S. is a major contributor to the market in North America, with penicillin and tetracycline being the two most widely used antibiotics in poultry animals.

Latin America is expected to be one of the most lucrative markets for poultry pharmaceuticals during the forecast period. The rising focus of multinational companies on Latin America and on specialized local players drives the market in this region. Chicken is a significantly large segment of the poultry pharmaceuticals market in Latin America due to the increased concentration of broilers to meet rising exports from the region and to cater to the growing global demand for meat. Brazil led the poultry pharmaceuticals market in Latin America in 2015 owing to the well-established poultry production and animal health industry in the country.

Players such as Merck Animal Health, Zoetis, Inc., Ceva Sante Animale, Elanco Animal Health, and Merial Animal Health dominate the global poultry pharmaceuticals market. Other significant companies operating in the market include Bayer AG, Virbac, and Bimeda.

1. Preface
     1.1. Report Scope and Market Segmentation 
     1.2. Research Highlights

2. Assumptions and Research Methodology
     2.1. Assumptions
     2.2. Acronyms Used
     2.3. Research Methodology

3. Executive Summary
     3.1. Global Poultry Pharmaceuticals Market Snapshot
     3.2. Market Opportunity Map
     3.3. Global Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, 2014–2024

4. Market Overview
     4.1. Product Overview
     4.2. Key Industry Events
     4.3. Key Market Indicators

5. Market Dynamics
     5.1. Market Drivers
            5.1.1. Greater Emphasis On Prevention And Wellness By Veterinarians And Owners
            5.1.2. Increased Consumption of Animal Protein Among Human Population
            5.1.3. Increased Epidemic of Poultry Diseases
            5.1.4. Demand of meat and protein source
            5.1.5. Evolution of Epizootic Avian Flu 
            5.1.6. Increasing Poultry Franchise Among Emerging Regions
            5.1.7. Government And Private Initiatives for Vaccination Program Among Poultry Farms
            5.1.2. Restraints
                     5.1.2.1. Stringent Regulations
                     5.1.2.2. High Medical Costs 
                     5.1.2.3. Rising Concern About the Use of Antibiotics and Growth Promoters in Food Animals
            5.1.3. Opportunities
                     5.1.3.1. Technological Development and Innovation
                     5.1.3.2. Significant Scope in Emerging Markets
     5.2. Porter’s Five Forces Analysis
     5.3. Value Chain Analysis
     5.4. Poultry Pharmaceuticals Market Outlook

6. Poultry Pharmaceuticals Market Analysis, by Product Type
     6.1. Introduction 
     6.2. Key Findings
     6.3. Global Poultry Pharmaceuticals Market Value Share Analysis, by Product Type
            6.3.1. Drugs
                     6.3.1.1. VETRIMOXIN
                     6.3.1.2. Other Drug Products
            6.3.2. Vaccines
                     6.3.2.1. INNOVAX
                     6.3.2.2. NOBILIS
                     6.3.2.3. Poulvac
                     6.3.2.4. Other Vaccine Products
            6.3.3. Feed Additive Medication
                     6.3.3.1. VIGOSINE
                     6.3.3.2. Amnovit 
                     6.3.3.3. Other Feed Additive Medication
     6.4. Key Trends
     6.5. Poultry Pharmaceuticals Market Attractiveness Analysis, by Product Type

7. Global Poultry Pharmaceuticals Market Analysis, by Animal Type
     7.1. Introduction
     7.2. Key Findings
     7.3. Global Poultry Pharmaceuticals Market Analysis, by Animal Type
            7.3.1. Chicken
            7.3.2. Turkey
            7.3.3. Duck
            7.3.4. Goose
            7.3.5. Others
     7.4. Poultry Pharmaceuticals Market Attractiveness Analysis, by Animal 
     7.5. Key Trends

8. Global Poultry Pharmaceuticals Market Value Share Analysis, by Region
     8.1. Global Market Scenario 
     8.2. North America
     8.3. Europe
     8.4. Asia Pacific
     8.5. Latin America
     8.6. Middle East and Africa

9. North America Poultry Pharmaceuticals Market Analysis
     9.1. North America Key Findings 
     9.2. North America Poultry Pharmaceuticals Market Overview 
     9.3. North America Market Value Share Analysis, by Country 
     9.4. North America Market Value Share Analysis, by Product Type 
     9.5. North America Market Value Share Analysis, by Animal Type 
     9.6. North America Market Attractiveness Analysis 
     9.7. North America Market Trends 

10. Latin America Poultry Pharmaceuticals Market Analysis
     10.1. Latin America Poultry Pharmaceuticals Market Analysis
     10.2. Key Findings
     10.3. Latin America Poultry Pharmaceuticals Market Overview
     10.4. Latin America Market Value Share Analysis, by Country
     10.5. Latin America Market Value Share Analysis, by Product Type
     10.6. Latin America Market Value Share Analysis, by Animal Type
     10.7. Latin America Market Attractiveness Analysis
     10.8. Latin America Market Trends

11. Europe Poultry Pharmaceuticals Market Analysis
     11.1. Key Findings
     11.2. Europe Poultry Pharmaceuticals Market Overview
     11.3. Europe Market Value Share Analysis, by Country
     11.4. Europe Market Forecast, by Product Type
     11.5. Europe Market Value Share Analysis, by Animal Type
     11.6. Europe Market Attractiveness Analysis
     11.7. Europe Market Trends

12. Asia Pacific Poultry Pharmaceuticals Market Analysis
     12.1. Key Findings
     12.2. Asia Pacific Poultry Pharmaceuticals Market Overview
     12.3. Asia Pacific Market Value Share Analysis, by Country
     12.4. Asia Pacific Market Value Share Analysis, by Product Type
     12.5. Asia Pacific Market Value Share Analysis, by Animal Type
     12.6. Asia Pacific Market Attractiveness Analysis
     12.7. Asia Pacific Market Trends

13. Middle East & Africa Poultry Pharmaceuticals Market Analysis
     13.1. Key Findings
     13.2. Middle East & Africa Poultry Pharmaceuticals Market Overview
     13.3. Middle East & Africa Market Value Share Analysis, by Country
     13.4. Middle East & Africa Market Value Share Analysis, by Product Type
     13.5. Middle East & Africa Market Value Share Analysis, by Animal Type
     13.6. Middle East & Africa Market Attractiveness Analysis
     13.7. Middle East & Africa Market Trends

14. Competition Landscape
     14.1. Poultry Pharmaceuticals Market Share Analysis By Company 
     14.2. Competition Matrix
     14.3. Company Profiles
            14.3.1. Bayer AG 
                     14.3.1.1. Company Details
                     14.3.1.2. Business Overview
                     14.3.1.3. Financial Overview
                     14.3.1.4. Strategic Overview
                     14.3.1.5. SWOT Analysis
            14.3.2. Bimeda
                     14.3.2.1. Company Details
                     14.3.2.2. Business Overview
                     14.3.2.3. Financial Overview
                     14.3.2.4. Strategic Overview
                     14.3.2.5. SWOT Analysis
            14.3.3. Ceva Sante Animale 
                     14.3.3.1. Company Details
                     14.3.3.2. Business Overview
                     14.3.3.3. Financial Overview
                     14.3.3.4. Strategic Overview
                     14.3.3.5. SWOT Analysis
            14.3.4. Elanco Animal Health (Eli Lilly and Company)
                     14.3.4.1. Company Details
                     14.3.4.2. Business Overview
                     14.3.4.3. Financial Overview
                     14.3.4.4. Strategic Overview
                     14.3.4.5. SWOT Analysis
            14.3.5. Merck Animal Health 
                     14.3.5.1. Company Details
                     14.3.5.2. Business Overview
                     14.3.5.3. Financial Overview
                     14.3.5.4. Strategic Overview
                     14.3.5.5. SWOT Analysis
            14.3.6. Merial Animal Health (Sanofi)
                     14.3.6.1. Company Details
                     14.3.6.2. Business Overview
                     14.3.6.3. Financial Overview
                     14.3.6.4. Strategic Overview
                     14.3.6.5. SWOT Analysis
            14.3.7. Virbac
                     14.3.7.1. Company Details
                     14.3.7.2. Business Overview
                     14.3.7.3. Financial Overview
                     14.3.7.4. Strategic Overview
                     14.3.7.5. SWOT Analysis
            14.3.8. Zoetis, Inc. 
                     14.3.8.1. Company Details
                     14.3.8.2. Business Overview
                     14.3.8.3. Financial Overview
                     14.3.8.4. Strategic Overview
                     14.3.8.5. SWOT Analysis

15. Recommendations

List of Figures

FIG. 1 Global Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, 2014–2024
FIG. 2 Global Poultry Pharmaceuticals Market Value Share Analysis, by Product Type, 2016 and 2024
FIG. 3 Global Poultry Drugs Market Revenue (US$ Mn), 2014–2024
FIG. 4 Global Poultry Vaccines Market Revenue, 2014-2024
FIG. 5 Global Feed Additive Medication Market Revenue (US$ Mn), 2014–2024
FIG. 6 Global Poultry VETRIMOXIN Drugs Market Revenue (US$ Mn), 2014–2024
FIG. 7 Global Poultry Other Drugs Products Market Revenue (US$ Mn), 2014–2024
FIG. 8 Global Poultry INNOVAX Vaccine Market Revenue (US$ Mn), 2014–2024
FIG. 9 Global Poultry NOBILIS Vaccine Market Revenue (US$ Mn), 2014–2024
FIG. 10 Global Poultry Poulvac Vaccine Market Revenue (US$ Mn), 2014–2024
FIG. 11 Global Poultry Other Vaccine Products Market Revenue (US$ Mn), 2014–2024
FIG. 12 Global Poultry VIGOSINE Feed Additive Medication Market Revenue (US$ Mn), 2014–2024
FIG. 13 Global Poultry Amnovit Feed Additive Medication Market Revenue (US$ Mn), 2014–2024
FIG. 14 Global Poultry Other Feed Additive Medication Market Revenue (US$ Mn), 2014–2024
FIG. 15 Poultry Pharmaceuticals Market Attractiveness Analysis, by Product Type, 2014-2024
FIG. 16 Global Poultry Pharmaceuticals Market Value Share Analysis, by Animal Type, 2016 and 2024
FIG. 17 Global Chicken Market Revenue (US$ Mn), 2014–2024
FIG. 18 Global Turkey Market Revenue (US$ Mn), 2014–2024
FIG. 19 Global Duck Market Revenue (US$ Mn), 2014–2024
FIG. 20 Global Goose Market Revenue (US$ Mn), 2014–2024
FIG. 21 Global Other Poultry Market Revenue (US$ Mn), 2014–2024
FIG. 22 Poultry Pharmaceuticals Market Attractiveness Analysis, by Animal Type
FIG. 23 Global Poultry Pharmaceuticals Market Value Share Analysis, by Region, 2016 and 2024
FIG. 24 Global Poultry Pharmaceuticals Market Attractiveness Analysis By Region, 2015–2024
FIG. 25 North America Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, 2014–2024
FIG. 26 North America Market Attractiveness Analysis, by Country
FIG. 27 North America Market Value Share Analysis, by Country, 2016 and 2024
FIG. 28 North America Market Value Share Analysis, by Product Type, 2016 and 2024
FIG. 29 North America Market Value Share Analysis, by Animal Type, 2016 and 2024
FIG. 30 Latin America Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, 2014–2024
FIG. 31 Latin America Market Attractiveness Analysis, by Country
FIG. 32 Latin America Market Value Share Analysis, by Country, 2016 and 2024
FIG. 33 Latin America Market Value Share Analysis, by Product Type, 2016 and 2024
FIG. 34 Latin America Market Value Share Analysis, by Animal Type, 2016 and 2024
FIG. 35 Europe Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, 2014–2024
FIG. 36 Europe Market Attractiveness Analysis, by Country
FIG. 37 Europe Market Value Share Analysis, by Country, 2016 and 2024
FIG. 38 Europe Market Value Share Analysis, by Product Type, 2016 and 2024
FIG. 39 Europe Market Value Share Analysis, by Animal Type, 2016 and 2024
FIG. 40 Asia Pacific Poultry Pharmaceuticals Market Size
FIG. 41 Asia Pacific Market Attractiveness Analysis, by Country
FIG. 42 Asia Pacific Market Value Share Analysis, by Country, 2016 and 2024
FIG. 43 Asia Pacific Market Value Share Analysis, by Product Type, 2016 and 2024
FIG. 44 Asia Pacific Market Value Share Analysis, by Animal Type, 2016 and 2024
FIG. 45 Middle East & Africa Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, 2014-2024
FIG. 46 Middle East & Africa Market Attractiveness Analysis, by Country, 2014-2024
FIG. 47 Middle East & Africa Market Value Share Analysis, by Product Type, 2016 and 2024
FIG. 48 Middle East & Africa Market Value Share Analysis, by Animal Type, 2016 and 2024
FIG. 49 Middle East & Africa Market Value Share Analysis,
FIG. 50 Global Poultry Pharmaceuticals Market Share Analysis By Company (2015)

List of Tables

TABLE 1 Global Poultry Pharmaceuticals Market Size (US$ Mn) and Volume (Units) Forecast, by Product Type, 2014-2024
TABLE 2 Global Poultry Drugs Market Size (US$ Mn) Forecast, by Product Type - Drugs, 2014-2024
TABLE 3 Global Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, by Product Type - Vaccines, 2014-2024
TABLE 4 Global Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, by Product Type - Feed Additive Medication, 2014-2024
TABLE 5 Global Poultry Pharmaceuticals Market Size (US$ Mn) and Volume (Units) Forecast, by Animal Type, 2014–2024
TABLE 6 Global Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, by Region, 2014–2024
TABLE 7 North America Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, by Country, 2014–2024
TABLE 8 North America Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
TABLE 9 North America Poultry Drugs Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
TABLE 10 North America Poultry Vaccines Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
TABLE 11 North America Poultry Feed Additive Drugs Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
TABLE 12 North America Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, by Animal Type, 2014–2024
TABLE 13 Latin America Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, by Country, 2014–2024
TABLE 14 Latin America Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
TABLE 15 Latin America Poultry Drugs Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
TABLE 16 Latin America Poultry Vaccines Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
TABLE 17 Latin America Poultry Feed Additive Medication Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
TABLE 18 Latin America Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, by Animal Type, 2014–2024
TABLE 19 Europe Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, by Country, 2014–2024
TABLE 20 Europe Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
TABLE 21 Europe Poultry Drugs Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
TABLE 22 Europe Poultry Vaccines Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
TABLE 23 Europe Poultry Feed Additive Medication Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
TABLE 24 Europe Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, by Animal Type, 2014–2024
TABLE 25 Asia Pacific Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, by Country, 2014-2024
TABLE 26 Asia Pacific Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, by Product Type, 2014-2024
TABLE 27 Asia Pacific Poultry Drugs Market Size (US$ Mn) Forecast, by Product Type, 2014-2024
TABLE 28 Asia Pacific Poultry Vaccines Market Size (US$ Mn) Forecast, by Product Type, 2014-2024
TABLE 29 Asia Pacific Poultry Feed Additive Medication Market Size (US$ Mn) Forecast, by Product Type, 2014-2024
TABLE 30 Asia Pacific Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, by Animal Type, 2014-2024
TABLE 31 Middle East & Africa Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
TABLE 32 Middle East & Africa Poultry Drugs Market Size (US$ Mn) Forecast, by Product Type, 2014-2024
TABLE 33 Middle East & Africa Poultry Vaccines Market Size (US$ Mn) Forecast, by Product Type, 2014-2024
TABLE 34 Middle East & Africa Poultry Feed Additive Drugs Market Size (US$ Mn) Forecast, by Product Type, 2014-2024
TABLE 35 Middle East & Africa Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, by Animal Type, 2014-2024
TABLE 36 Middle East & Africa Poultry Pharmaceuticals Market Size (US$ Mn) Forecast, by Country, 2014-2024

This report on the poultry pharmaceuticals market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of poultry pharmaceuticals such as drugs, vaccines, and feed additive medication, as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global poultry pharmaceuticals market with respect to the leading market segments based on major pharmaceutical products, animal types, and geographies.

The poultry pharmaceuticals market has been studied based on major product segments and their regional as well as national markets. Based on product type, the global market has been categorized into three major segments: drugs, vaccines, and feed additive medication. Based on animal type, the global market has been categorized into five major segments: chicken, turkey, duck, goose, and others (emus, etc.). The market for these segments has been extensively analyzed based on their utility, sales, and geographic presence. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all segments, considering 2015 as the base year.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the poultry pharmaceuticals market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.

Geographically, the poultry pharmaceuticals market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Each regional market for poultry pharmaceuticals has been further categorized into major national markets such as the U.S, Canada, Germany, the U.K., India, China, and Brazil. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with CAGR % from 2016 to 2024 are provided for all the regions and nations considering 2015 as the base year.

The report also profiles key players operating in the poultry pharmaceuticals market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Bayer AG, Bimeda, Ceva Sante Animale, Elanco Animal Health (Eli Lilly and Company), Merck Animal Health, Merial Animal Health (Sanofi), Virbac, and Zoetis, Inc.

The global poultry pharmaceuticals market has been segmented as given below:

Global Poultry Pharmaceuticals Market, by Product Type

  • Drugs
    • VETRIMOXIN
    • Other Drug Products
  • Vaccines
    • INNOVAX
    • NOBILIS
    • Poulvac
    • Other Vaccine Products
  • Feed Additive Medication
    • VIGOSINE
    • Amnovit
    • Other Feed Additive Medication

Global Poultry Pharmaceuticals Market, by Animal Type

  • Chicken
  • Turkey
  • Duck
  • Goose
  • Others

Global Poultry Pharmaceuticals Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Rest of Middle East & Africa


 
 
Back To Top